Hypoxia-Inducible Factor-1α Is Essential for Hypoxia-Induced Mesenchymal Stem Cell Mobilization into the Peripheral Blood

Stem Cells and Development

Volumn 20, Issue 11, 2011, Pages 1961-1971

  Liu, Lizhen ^a   yu, Qin ^b   Lin, Jie ^b   Lai, Xiaoyu ^a   Cao, Weijie ^a   du, Kaili ^a   Wang, Yingjia ^a   wu, Kangni ^a   hu, Yongxian ^a   Zhang, Lifei ^a   Xiao, Haowen ^a   Duan, Yanping ^b   Huang, He ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDAZOLE DERIVATIVE; LIFICIGUAT; STROMAL CELL DERIVED FACTOR 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; ANOXIA; ARTICLE; BLOOD; BLOOD CELL; BONE MARROW; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CLONOGENIC ASSAY; DRUG ANTAGONISM; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANOXIA; BLOOD CELLS; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; COLONY-FORMING UNITS ASSAY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOPHENOTYPING; INDAZOLES; MALE; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862832883     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0453     Document Type: Article

References (55)

1. Pittenger M.F., AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
2. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
3. Long X, M Olszewski, W Huang and M Kletzel. (2005). Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14:65-69.
4. Barry FP and JM Murphy. (2004). Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
5. Alhadlaq A and JJ Mao. (2004). Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13:436-448.
6. Aicher A, AM Zeiher and S Dimmeler. (2005). Mobilizing endothelial progenitor cells. Hypertension 45:321-325.
7. Levesque J.P., IG Winkler, SR Larsen and JE Rasko. (2007). Mobilization of bone marrow-derived progenitors. Handb Exp Pharmacol (180):3-36.
8. Pelus LM. (2008). Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand. Curr Opin Hematol 15:285-292.
9. Pitchford S.C., MJ Hahnel, CP Jones and SM Rankin. (2010). Troubleshooting: quantification of mobilization of progenitor cell subsets from bone marrow in vivo. J Pharmacol Toxicol Methods 61:113-121.
10. Cashen A.F., D Link, S Devine and J DiPersio. (2004). Cytokines and stem cell mobilization for autologous and allogeneic transplantation. Curr Hematol Rep 3:406-412.
11. Huang X.J., DH Liu, KY Liu, LP Xu, H Chen, W Han, YH Chen, XH Zhang and DP Lu. (2009). Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant 15:257-265.
12. Takano H, M Ohtsuka, H Akazawa, H Toko, M Harada, H Hasegawa, T Nagai and I Komuro. (2003). Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 9:1121-1127.
13. Pitchford S.C., RC Furze, CP Jones, AM Wengner and SM Rankin. (2009). Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4:62-72.
14. Lazarus H.M., SE Haynesworth, SL Gerson and AI Caplan. (1997). Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother 6:447-455.
15. Wexler S.A., C Donaldson, P Denning-Kendall, C Rice, B Bradley and JM Hows. (2003). Adult bone marrow is a rich source of human mesenchymal “stem” cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374.
16. Roufosse C.A., NC Direkze, WR Otto and NA Wright. (2004). Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36:585-597.
17. He Q, C Wan and G Li. (2007). Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25:69-77.
18. Rochefort G.Y., B Delorme, A Lopez, O Herault, P Bonnet, P Charbord, V Eder and J Domenech. (2006). Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24:2202-2208.
19. Carreras A, I Almendros, I Acerbi, JM Montserrat, D Navajas and R Farre. (2009). Obstructive apneas induce early release of mesenchymal stem cells into circulating blood. Sleep 32:117-119.
20. Ceradini D.J., AR Kulkarni, MJ Callaghan, OM Tepper, N Bastidas, ME Kleinman, JM Capla, RD Galiano, JP Levine and GC Gurtner. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
21. Semenza GL. (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474-1480.
22. Ceradini DJ and GC Gurtner. (2005). Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15:57-63.
23. Du R, KV Lu, C Petritsch, P Liu, R Ganss, E Passegue, H Song, S Vandenberg, RS Johnson, Z Werb and G Bergers. (2008). HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206-220.
24. Shin D.H., JH Kim, YJ Jung, KE Kim, JM Jeong, YS Chun and JW Park. (2007). Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Cancer Lett 255:107-116.
25. Barbash I.M., P Chouraqui, J Baron, MS Feinberg, S Etzion, A Tessone, L Miller, E Guetta, D Zipori, LH Kedes, RA Kloner and J Leor. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108:863-868.
26. Ratajczak M.Z., H Lee, M Wysoczynski, W Wan, W Marlicz, MJ Laughlin, M Kucia, A Janowska-Wieczorek and J Ratajczak. (2010). Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 24:976-985.
27. Yang J.X., WL Tang and XX Wang. (2010). Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy 12:251-259.
28. Nakanishi K, F Tajima, A Nakamura, S Yagura, T Ookawara, H Yamashita, K Suzuki, N Taniguchi and H Ohno. (1995). Effects of hypobaric hypoxia on antioxidant enzymes in rats. J Physiol 489 (Pt 3):869-876.
29. Chen Y, JZ Shao, LX Xiang, XJ Dong and GR Zhang. (2008). Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 40:815-820.
30. Ferrara N, HP Gerber and J LeCouter. (2003). The biology of VEGF and its receptors. Nat Med 9:669-676.
31. Forsythe J.A., BH Jiang, NV Iyer, F Agani, SW Leung, RD Koos and GL Semenza. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
32. Hooper A.T., JM Butler, DJ Nolan, A Kranz, K Iida, M Kobayashi, HG Kopp, K Shido, I Petit, K Yanger, D James, L Witte, Z Zhu, Y Wu, B Pytowski, Z Rosenwaks, V Mittal, TN Sato and S Rafii. (2009). Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4:263-274.
33. Perkins S and RA Fleischman. (1990). Stromal cell progeny of murine bone marrow fibroblast colony-forming units are clonal endothelial-like cells that express collagen IV and laminin. Blood 75:620-625.
34. Delorme B and P Charbord. (2007). Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med 140:67-81.
35. Gao J, JE Dennis, RF Muzic, M Lundberg and AI Caplan. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20.
36. Francois S, M Bensidhoum, M Mouiseddine, C Mazurier, B Allenet, A Semont, J Frick, A Sache, S Bouchet, D Thierry, P Gourmelon, NC Gorin and A Chapel. (2006). Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24:1020-1029.
37. Ivan M, K Kondo, H Yang, W Kim, J Valiando, M Ohh, A Salic, JM Asara, WS Lane and WG Kaelin, Jr. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468.
38. Semenza GL. (2001). HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107:1-3.
39. Asosingh K, H De Raeve, M de Ridder, GA Storme, A Willems, I Van Riet, B Van Camp and K Vanderkerken. (2005). Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica 90:810-817.
40. Levesque J.P., IG Winkler, J Hendy, B Williams, F Helwani, V Barbier, B Nowlan and SK Nilsson. (2007). Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells 25:1954-1965.
41. Lennon D.P., JM Edmison and AI Caplan. (2001). Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 187:345-355.
42. Iyer N.V., LE Kotch, F Agani, SW Leung, E Laughner, RH Wenger, M Gassmann, JD Gearhart, AM Lawler, AY Yu and GL Semenza. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
43. Sun H.L., YN Liu, YT Huang, SL Pan, DY Huang, JH Guh, FY Lee, SC Kuo and CM Teng. (2007). YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 26:3941-3951.
44. Yeo E.J., YS Chun, YS Cho, J Kim, JC Lee, MS Kim and JW Park. (2003). YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 95:516-525.
45. Pan S.L., JH Guh, CY Peng, SW Wang, YL Chang, FC Cheng, JH Chang, SC Kuo, FY Lee and CM Teng. (2005). YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. J Pharmacol Exp Ther 314:35-42.
46. Senger D.R., L Van de Water, LF Brown, JA Nagy, KT Yeo, TK Yeo, B Berse, RW Jackman, AM Dvorak and HF Dvorak. (1993). Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12:303-324.
47. Dafni H, L Landsman, B Schechter, F Kohen and M Neeman. (2002). MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 15:120-131.
48. Hattori K, S Dias, B Heissig, NR Hackett, D Lyden, M Tateno, DJ Hicklin, Z Zhu, L Witte, RG Crystal, MA Moore and S Rafii. (2001). Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005-1014.
49. Kopp H.G., ST Avecilla, AT Hooper, SV Shmelkov, CA Ramos, F Zhang and S Rafii. (2005). Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood 106:505-513.
50. Kopp H.G., AT Hooper, ST Avecilla and S Rafii. (2009). Functional heterogeneity of the bone marrow vascular niche. Ann NY Acad Sci 1176:47-54.
51. Hung S.C., RR Pochampally, SC Hsu, C Sanchez, SC Chen, J Spees and DJ Prockop. (2007). Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. Plos ONE 2:e416.
52. Annabi B, YT Lee, S Turcotte, E Naud, RR Desrosiers, M Champagne, N Eliopoulos, J Galipeau and R Beliveau. (2003). Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21:337-347.
53. Rosova I, M Dao, B Capoccia, D Link and JA Nolta. (2008). Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-2182.
54. Wynn R.F., CA Hart, C Corradi-Perini, L O'Neill, CA Evans, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645.
55. Luciano J.A., T Tan, Q Zhang, E Huang, P Scholz and HR Weiss. (2008). Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Cell Physiol Biochem 21:421-428.